Skip to content

Edwards Lifesciences EW Income Statement

TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
$6.3B+14.1%$6.07B+11.5%$5.88B+10.6%$5.69B+9.1%$5.52B+7.9%
$1.4B+23.2%$1.33B+19.4%$1.28B+19.2%$1.2B+12.9%$1.13B+8.3%
$4.91B+11.8%$4.73B+9.5%$4.6B+8.4%$4.48B+8.2%$4.39B+7.8%
77.9%-1.6pp78%-1.4pp78.2%-1.6pp78.9%-0.7pp79.5%-0.1pp
$1.09B+3.5%$1.08B+2.5%$1.08B+5.7%$1.06B+4.1%$1.05B+6.7%
$2.14B+17.3%$2.09B+16.5%$1.97B+15.2%$1.88B+12.3%$1.83B+11.6%
$1.35B-5.4%$1.26B-8.3%$1.43B+0.9%$1.47B+2.9%$1.42B+7.5%
21.4%-4.4pp20.8%-4.5pp24.2%-2.3pp25.8%-1.6pp25.8%-0.1pp
$1.3B-19.4%$1.27B-17.8%$1.57B+3.1%$1.63B+7.7%$1.61B+15.0%
$224.9M+27.7%$216.9M+42.6%$235.8M+67.1%$220.4M+44.0%$176.1M+14.4%
$1.1B-73.8%$1.07B-74.3%$1.37B-67.1%$4.15B+182%$4.18B+196%
17.4%-58.3pp17.7%-59.1pp23.2%-54.9pp73%+44.7pp75.7%+48.1pp
$1.88-73.1%$1.83-73.7%$2.32-66.5%$6.95+186%$7.00+202%
$1.51B-4.4%$1.42B-7.4%$1.58B+1.3%$1.62B+2.6%$1.58B+7.1%
23.9%-4.6pp23.4%-4.8pp26.9%-2.5pp28.5%-1.8pp28.6%-0.2pp
$1.35B-5.4%$1.26B-8.3%$1.43B+0.9%$1.47B+2.9%$1.42B+7.5%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What is Edwards Lifesciences's revenue?
Edwards Lifesciences (EW) generated $6.3B in revenue over the trailing twelve months, up 14.1% year over year.
Is Edwards Lifesciences profitable?
Edwards Lifesciences reported $1.1B in net income over the trailing twelve months, a 17.4% net margin.
What are Edwards Lifesciences's profit margins?
Gross margin is 77.9% and operating margin is 21.4%, with a 17.4% net margin.
What is Edwards Lifesciences's earnings per share?
Edwards Lifesciences's diluted EPS over the trailing twelve months is $1.88.
Where does Edwards Lifesciences's income statement data come from?
Every line is extracted from Edwards Lifesciences's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.